Real-World Breast Cancer Studies Report Higher Response Rates Than Randomized Trials
A meta-epidemiological analysis of 86 studies found that real-world cohorts of patients taking CDK4/6 inhibitors for hormone receptor-positive, HER2-negative advanced ...
